Six experts resign from Trump HIV/AIDS panel

June 19, 2017

Six top health advisors have resigned from Donald Trump's advisory council on HIV/AIDS, complaining that the US president doesn't really care about combatting the illness.

In a letter published Friday in Newsweek, Scott Schoettes said the Trump administration has "no strategy" on AIDS and that he and his five colleagues will be more effective advocating for change from the outside.

Schoettes, counsel and HIV project director at Lambda Legal, resigned Tuesday from the Presidential Advisory Council on HIV/AIDS, along with Lucy Bradley-Springer, Gina Brown, Ulysses Burley III, Michelle Ogle and Grissel Granados.

The council can have up to 25 members.

"The Trump administration has no strategy to address the on-going HIV/AIDS epidemic, seeks zero input from experts to formulate HIV policy, and—most concerning—pushes legislation that will harm people living with HIV and halt or reverse important gains made in the fight against this disease," Schoettes wrote.

"If we do not ensure that US leadership at the executive and legislative levels are informed by experience and expertise, real people will be hurt and some will even die," he said.

"Because we do not believe the Trump administration is listening to—or cares—about the communities we serve as members of PACHA, we have decided it is time to step down."

PACHA, which was created in 1995, includes , researchers, , faith leavers, HIV advocates and people living with HIV. Its helps inform the National HIV/AIDS Strategy, which was last revised in 2015.

Schoettes noted that Trump failed to appoint a head of the White House Office of National AIDS Policy, a senior advisory position, and took down the Office of National AIDS Policy website the very day he took office—on January 20—and has yet to replace it.

He also stressed that changes Trump and his fellow Republicans in Congress are seeking to the sweeping care reform initiated by former president Barack Obama would be "extremely harmful" to people living with HIV or AIDS.

Schoettes cited data showing that only 40 percent of people living with HIV in the United States can access life-saving medications.

Explore further: National Archives to White House: Save all Trump tweets

Related Stories

The health consequences of Trump's global gag order

May 19, 2017

President Donald Trump recently signed an executive order that media reports say could obstruct nearly US$8.8 billion the U.S. spends annually to fight deadly diseases abroad. Here, Maureen Miller, a Columbia University Medical ...

Trump doesn't rule out 'amended' Obamacare: WSJ

November 11, 2016

US President-elect Donald Trump has said he will consider an "amended" version of Barack Obama's signature health care law—a sign of a shift in position after repeatedly vowing on the campaign trail that he would repeal ...

Recommended for you

Team tests best delivery mode for potential HIV vaccine

June 20, 2017

For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

Understanding HIV's persistence

June 19, 2017

Most cells in the human body have a limited lifespan, typically dying after several days or weeks. And yet, HIV-1 infected cells manage to persist in the body for decades. Current treatment for HIV is very effective at suppressing ...

Researchers uncover clues about how HIV virus mutates

June 1, 2017

A new study published in Cell Host & Microbe led by researchers at Fred Hutchinson Cancer Research Center completely maps all mutations that help the HIV virus evolve away from a single broadly neutralizing antibody, known ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.